- Home
- POAI vs IDAI Comparison
POAI vs IDAI Comparison
Compare POAI & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- IDAI
- Stock Information
- Founded
- POAI 2002
- IDAI 2016
- Country
- POAI United States
- IDAI United States
- Employees
- POAI N/A
- IDAI N/A
- Industry
- POAI Industrial Specialties
- IDAI Computer Software: Prepackaged Software
- Sector
- POAI Health Care
- IDAI Technology
- Exchange
- POAI Nasdaq
- IDAI Nasdaq
- Market Cap
- POAI 9.7M
- IDAI 9.7M
- IPO Year
- POAI N/A
- IDAI N/A
- Fundamental
- Price
- POAI $1.45
- IDAI $2.68
- Analyst Decision
- POAI Hold
- IDAI
- Analyst Count
- POAI 1
- IDAI 0
- Target Price
- POAI N/A
- IDAI N/A
- AVG Volume (30 Days)
- POAI 483.7K
- IDAI 132.9K
- Earning Date
- POAI 03-27-2025
- IDAI 03-31-2025
- Dividend Yield
- POAI N/A
- IDAI N/A
- EPS Growth
- POAI N/A
- IDAI N/A
- EPS
- POAI N/A
- IDAI N/A
- Revenue
- POAI $1,484,223.00
- IDAI $2,160,186.00
- Revenue This Year
- POAI N/A
- IDAI N/A
- Revenue Next Year
- POAI $569.48
- IDAI $139.59
- P/E Ratio
- POAI N/A
- IDAI N/A
- Revenue Growth
- POAI N/A
- IDAI N/A
- 52 Week Low
- POAI $0.55
- IDAI $0.15
- 52 Week High
- POAI $3.67
- IDAI $8.96
- Technical
- Relative Strength Index (RSI)
- POAI 50.83
- IDAI 41.42
- Support Level
- POAI $1.39
- IDAI $2.43
- Resistance Level
- POAI $1.97
- IDAI $3.22
- Average True Range (ATR)
- POAI 0.14
- IDAI 0.30
- MACD
- POAI -0.02
- IDAI -0.14
- Stochastic Oscillator
- POAI 14.88
- IDAI 23.36
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About IDAI T Stamp Inc.
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility.